BR9909024B1 - derivado de piridina, produto farmacêutico contendo o mesmo, composição farmacêutica e seus usos. - Google Patents
derivado de piridina, produto farmacêutico contendo o mesmo, composição farmacêutica e seus usos.Info
- Publication number
- BR9909024B1 BR9909024B1 BRPI9909024-4A BR9909024A BR9909024B1 BR 9909024 B1 BR9909024 B1 BR 9909024B1 BR 9909024 A BR9909024 A BR 9909024A BR 9909024 B1 BR9909024 B1 BR 9909024B1
- Authority
- BR
- Brazil
- Prior art keywords
- product containing
- pyridine derivative
- pharmaceutical
- pharmaceutical composition
- pharmaceutical product
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 229940127557 pharmaceutical product Drugs 0.000 title 1
- 150000003222 pyridines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
- C07D213/643—2-Phenoxypyridines; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7808398 | 1998-03-25 | ||
| JP25155298 | 1998-09-04 | ||
| PCT/JP1999/001425 WO1999048871A1 (en) | 1998-03-25 | 1999-03-19 | Pyridine derivative and pharmaceutical containing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR9909024A BR9909024A (pt) | 2000-12-05 |
| BR9909024B1 true BR9909024B1 (pt) | 2010-05-18 |
Family
ID=26419157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI9909024-4A BR9909024B1 (pt) | 1998-03-25 | 1999-03-19 | derivado de piridina, produto farmacêutico contendo o mesmo, composição farmacêutica e seus usos. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6511995B1 (pt) |
| EP (1) | EP1066261B1 (pt) |
| JP (1) | JP4386579B2 (pt) |
| KR (1) | KR100365063B1 (pt) |
| CN (1) | CN1115334C (pt) |
| AR (1) | AR015733A1 (pt) |
| AT (1) | ATE310726T1 (pt) |
| AU (1) | AU759969B2 (pt) |
| BR (1) | BR9909024B1 (pt) |
| CA (1) | CA2322953C (pt) |
| DE (1) | DE69928509T2 (pt) |
| DK (1) | DK1066261T3 (pt) |
| ES (1) | ES2251827T3 (pt) |
| HK (1) | HK1036273A1 (pt) |
| ID (1) | ID27479A (pt) |
| MY (1) | MY125650A (pt) |
| TW (1) | TW585856B (pt) |
| WO (1) | WO1999048871A1 (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HN1998000027A (es) | 1998-08-19 | 1999-06-02 | Bayer Ip Gmbh | Arilsulfonamidas y analagos |
| EP1150955A2 (en) * | 1999-02-04 | 2001-11-07 | Millennium Pharmaceuticals, Inc. | G-protein coupled heptahelical receptor binding compounds and methods of use thereof |
| CA2573223C (en) * | 2004-08-06 | 2013-05-21 | Otsuka Pharmaceutical Co., Ltd. | Aromatic compound |
| ZA200804445B (en) | 2005-12-05 | 2009-11-25 | Otsuka Pharma Co Ltd | Diarylether derivatives as antitumor agents |
| UA95978C2 (ru) | 2006-10-02 | 2011-09-26 | Оцука Фармас'Ютікел Ко., Лтд. | Ингибитор активации stat3/5 |
| ITRM20070088A1 (it) * | 2007-02-19 | 2008-08-20 | Francesco Fringuelli | Composti derivati della colchicina, procedimento per la loro preparazione e usi in campo medico. |
| TWI440638B (zh) * | 2007-10-30 | 2014-06-11 | Otsuka Pharma Co Ltd | 雜環化合物及其藥學組成物 |
| JP5688918B2 (ja) * | 2009-04-28 | 2015-03-25 | 大塚製薬株式会社 | 医薬組成物 |
| BR112012015868A2 (pt) | 2009-12-11 | 2017-06-20 | Autifony Therapeutics Ltd | derivados de imidazolidinadiona |
| AU2011211306B2 (en) * | 2010-01-29 | 2016-07-07 | Otsuka Pharmaceutical Co., Ltd. | Di - substituted pyridine derivatives as anticancers |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW352384B (en) * | 1992-03-24 | 1999-02-11 | Hoechst Ag | Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals |
| US6022884A (en) * | 1997-11-07 | 2000-02-08 | Amgen Inc. | Substituted pyridine compounds and methods of use |
-
1999
- 1999-03-17 AR ARP990101167A patent/AR015733A1/es active IP Right Grant
- 1999-03-19 KR KR1020007010516A patent/KR100365063B1/ko not_active IP Right Cessation
- 1999-03-19 BR BRPI9909024-4A patent/BR9909024B1/pt not_active IP Right Cessation
- 1999-03-19 ES ES99909286T patent/ES2251827T3/es not_active Expired - Lifetime
- 1999-03-19 JP JP2000537854A patent/JP4386579B2/ja not_active Expired - Lifetime
- 1999-03-19 CA CA002322953A patent/CA2322953C/en not_active Expired - Fee Related
- 1999-03-19 DK DK99909286T patent/DK1066261T3/da active
- 1999-03-19 ID IDW20001911A patent/ID27479A/id unknown
- 1999-03-19 AU AU28544/99A patent/AU759969B2/en not_active Ceased
- 1999-03-19 DE DE69928509T patent/DE69928509T2/de not_active Expired - Lifetime
- 1999-03-19 CN CN99804271A patent/CN1115334C/zh not_active Expired - Fee Related
- 1999-03-19 MY MYPI99001052A patent/MY125650A/en unknown
- 1999-03-19 WO PCT/JP1999/001425 patent/WO1999048871A1/en active IP Right Grant
- 1999-03-19 AT AT99909286T patent/ATE310726T1/de not_active IP Right Cessation
- 1999-03-19 EP EP99909286A patent/EP1066261B1/en not_active Expired - Lifetime
- 1999-03-19 US US09/646,935 patent/US6511995B1/en not_active Expired - Fee Related
- 1999-03-25 TW TW088104708A patent/TW585856B/zh not_active IP Right Cessation
-
2001
- 2001-09-20 HK HK01106636A patent/HK1036273A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2322953A1 (en) | 1999-09-30 |
| EP1066261B1 (en) | 2005-11-23 |
| EP1066261A1 (en) | 2001-01-10 |
| CN1115334C (zh) | 2003-07-23 |
| KR20010034628A (ko) | 2001-04-25 |
| CN1294581A (zh) | 2001-05-09 |
| ES2251827T3 (es) | 2006-05-01 |
| ATE310726T1 (de) | 2005-12-15 |
| ID27479A (id) | 2001-04-12 |
| WO1999048871A1 (en) | 1999-09-30 |
| DE69928509T2 (de) | 2006-08-10 |
| AU759969B2 (en) | 2003-05-01 |
| DK1066261T3 (da) | 2006-01-30 |
| CA2322953C (en) | 2009-05-05 |
| AU2854499A (en) | 1999-10-18 |
| TW585856B (en) | 2004-05-01 |
| BR9909024A (pt) | 2000-12-05 |
| AR015733A1 (es) | 2001-05-16 |
| DE69928509D1 (de) | 2005-12-29 |
| HK1036273A1 (en) | 2001-12-28 |
| JP4386579B2 (ja) | 2009-12-16 |
| US6511995B1 (en) | 2003-01-28 |
| MY125650A (en) | 2006-08-30 |
| JP2002507601A (ja) | 2002-03-12 |
| KR100365063B1 (ko) | 2002-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL152490A0 (en) | Pyridine derivatives and pharmaceutical compositions containing the same | |
| NO20024175D0 (no) | Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme | |
| DZ2964A1 (fr) | Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant. | |
| NO20011216L (no) | Azetidinderivater, deres fremstilling og medikamenter inneholdende forbindelsene | |
| EE9900018A (et) | Asendatud püridiinid, nende kasutamine ja farmatseutilised kompositsioonid | |
| MA26548A1 (fr) | Compositions pharmaceutiques topiques contenant des derives de resorcinol. | |
| IS4309A (is) | Nýjar erýþrómýsin afleiður, sem og læknislyf sem innihalda þær | |
| NO20016038D0 (no) | Benzenderivater, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende de samme | |
| MA26537A1 (fr) | Derives de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant. | |
| BR9805993B1 (pt) | composição farmacêutica de aerossol. | |
| ZA200007638B (en) | Pyrazoline derivatives, their preparation and application as medicaments. | |
| DK1112266T3 (da) | Substituerede 4-amino-2-arylpyrimidiner, fremstilling og anvendelse deraf og farmaceutiske præparater indeholdende dem | |
| IL140525A0 (en) | 2-aminopyridine derivatives, their use as medicines and pharmaceutical compositions containing them | |
| HUP0103590A3 (en) | Nucleophile substituted ecteinascidins and n-oxide ecteinascidins, the pharmaceutical compositions containing them and their use | |
| BR9710560B1 (pt) | Composição farmacêutica contendo clopidogrel e sinvastatina, bem como seus usos. | |
| NO20030800D0 (no) | Aminoalkylbenzoyl-benzofuran- eller benzotiofenderivater, fremgangsmåte forderes fremstilling og preparater inneholdende de samme | |
| HK1015789A1 (en) | Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use. | |
| HUP0203722A3 (en) | Substituted phenyl-piperazine derivatives, pharmaceutical compositions containing them and their use | |
| ZA200102589B (en) | Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof. | |
| NO20003662D0 (no) | Syntetiske polysakkarider, fremgangsmÕte for fremstilling derav og farmasøytiske preparater inneholdende slike | |
| BR9909024B1 (pt) | derivado de piridina, produto farmacêutico contendo o mesmo, composição farmacêutica e seus usos. | |
| MA26802A1 (fr) | Derives de streptogramine, leur preparation et les compositions qui les contiennent. | |
| IS5730A (is) | Setin tíazóló-pýridazín afleiða, lyfjasamsetningar gerðar úr henni | |
| HK1051533A1 (en) | Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use. | |
| NO308362B1 (no) | 10,13,15-trioksatrisyklo[9.2.1.19.6]pentadekanonderivater, fremgangsmÕte for deres fremstilling og legemidler som inneholder disse forbindelsene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 18/05/2010, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B24C | Patent annual fee: request for for restoration |
Free format text: REFERENTE A 13A ANUIDADE. |
|
| B24H | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi) | ||
| B24F | Patent annual fee: publication cancelled |
Free format text: ANULADA A PUBLICACAO CODIGO 24.8 NA RPI NO 2259 DE 22/04/2014 POR TER SIDO INDEVIDA. |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 13A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2607 DE 22-12-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |